Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
Abstract Treatment of locally advanced, unresectable head and neck squamous cell carcinoma (HNSCC) often yields only modest results with radiochemotherapy (RCT) as standard of care. Prognostic features related to outcome upon RCT might be highly valuable to improve treatment. Monocarboxylate transpo...
Saved in:
Main Authors: | Martin Leu, J. Kitz, Y. Pilavakis, S. Hakroush, H. A. Wolff, M. Canis, S. Rieken, M. A. Schirmer |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/65dee9ff75eb467db2485a259080b37c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.
by: Marieangela C Wilson, et al.
Published: (2013) -
Cooperative transport mechanism of human monocarboxylate transporter 2
by: Bo Zhang, et al.
Published: (2020) -
Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
by: Linda S. Forero-Quintero, et al.
Published: (2017) -
Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
by: Philipp Baumeister, et al.
Published: (2021) -
Regulation of monocarboxylic acid transporter-1 by cAMP dependent vesicular trafficking in brain microvascular endothelial cells.
by: Amy L Uhernik, et al.
Published: (2014)